Cargando…

High-Throughput UHPLC-MS to Screen Metabolites in Feces for Gut Metabolic Health

Feces are the product of our diets and have been linked to diseases of the gut, including Chron’s disease and metabolic diseases such as diabetes. For screening metabolites in heterogeneous samples such as feces, it is necessary to use fast and reproducible analytical methods that maximize metabolit...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Zawadzki, Andressa, Thiele, Maja, Suvitaival, Tommi, Wretlind, Asger, Kim, Min, Ali, Mina, Bjerre, Annette F., Stahr, Karin, Mattila, Ismo, Hansen, Torben, Krag, Aleksander, Legido-Quigley, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950041/ https://www.ncbi.nlm.nih.gov/pubmed/35323654 http://dx.doi.org/10.3390/metabo12030211

Ejemplares similares

Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication
por: Israelsen, Mads, et al.
Publicado: (2021)

Describing the fecal metabolome in cryogenically collected samples from healthy participants
por: Trošt, Kajetan, et al.
Publicado: (2020)

Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial
por: Wretlind, Asger, et al.
Publicado: (2022)

Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes
por: Wretlind, Asger, et al.
Publicado: (2023)

Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials
por: Wretlind, Asger, et al.
Publicado: (2023)

Circulating Metabolites and Lipids Are Associated to Diabetic Retinopathy in Individuals With Type 1 Diabetes
por: Curovic, Viktor Rotbain, et al.
Publicado: (2020)

Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial
por: Zobel, Emilie H, et al.
Publicado: (2021)

Lipidomics of human adipose tissue reveals diversity between body areas
por: Al-Sari, Naba, et al.
Publicado: (2020)

Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Is Associated With Disturbances in TCA, Lipid, and Glucose Metabolism
por: Hansen, Christian S., et al.
Publicado: (2022)

Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes
por: Tofte, Nete, et al.
Publicado: (2019)

42.3 METABOLOMICS APPROACHES TO STUDY METABOLIC CO-MORBIDITIES IN PSYCHOTIC DISORDERS
por: Hyötyläinen, Tuulia, et al.
Publicado: (2018)

Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes
por: Ferreira-Divino, Luis F., et al.
Publicado: (2022)

Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Tougaard, Ninna H., et al.
Publicado: (2022)

Precision diagnostic approach to predict 5-year risk for microvascular complications in type 1 diabetes
por: Al-Sari, Naba, et al.
Publicado: (2022)

Author Correction: Intravital imaging of islet Ca(2+) dynamics reveals enhanced β cell connectivity after bariatric surgery in mice
por: Akalestou, Elina, et al.
Publicado: (2021)

Intravital imaging of islet Ca(2+) dynamics reveals enhanced β cell connectivity after bariatric surgery in mice
por: Akalestou, Elina, et al.
Publicado: (2021)

Large Variations in Risk of Hepatocellular Carcinoma and Mortality in Treatment Naïve Hepatitis B Patients: Systematic Review with Meta-Analyses
por: Thiele, Maja, et al.
Publicado: (2014)

Decreased branched-chain amino acids and elevated fatty acids during antecedent hypoglycemia in type 1 diabetes
por: She, Rui, et al.
Publicado: (2023)

Lipidomic Abnormalities During the Pathogenesis of Type 1 Diabetes: a Quantitative Review
por: Suvitaival, Tommi
Publicado: (2020)

Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s disease
por: Xu, Jin, et al.
Publicado: (2020)

Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysis
por: Thiele, Maja, et al.
Publicado: (2013)

Deregulation of the Purine Pathway in Pre-Transplant Liver Biopsies Is Associated with Graft Function and Survival after Transplantation
por: Xu, Jin, et al.
Publicado: (2020)

Prediction of Type 1 Diabetes at Birth: Cord Blood Metabolites vs Genetic Risk Score in the Norwegian Mother, Father, and Child Cohort
por: Tapia, German, et al.
Publicado: (2021)

Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post‐hoc analysis of a randomized crossover trial
por: Al‐Sari, Naba, et al.
Publicado: (2021)

Analytical Methodology for a Metabolome Atlas of Goat’s Plasma, Milk and Feces Using (1)H-NMR and UHPLC-HRMS
por: Martias, Cécile, et al.
Publicado: (2021)

Characterization of the global metabolic profile of liquiritin in rat plasma, urine, bile and feces based on UHPLC-FT-ICR MS
por: Ma, Li, et al.
Publicado: (2018)

Artificial intelligence outperforms standard blood-based scores in identifying liver fibrosis patients in primary care
por: Blanes-Vidal, Victoria, et al.
Publicado: (2022)

Optimization of Sample Preparation for Metabolomics Exploration of Urine, Feces, Blood and Saliva in Humans Using Combined NMR and UHPLC-HRMS Platforms
por: Martias, Cécile, et al.
Publicado: (2021)

Automated genotyping of microsatellite loci from feces with high throughput sequences
por: Salado, Isabel, et al.
Publicado: (2021)

Determination of Prostaglandins (Carboprost, Cloprostenol, Dinoprost, Dinoprostone, Misoprostol, Sulprostone) by UHPLC-MS/MS in Toxicological Investigations
por: Szpot, Paweł, et al.
Publicado: (2023)

Hepatorenal Index by B‐Mode Ratio Versus Imaging and Fatty Liver Index to Diagnose Steatosis in Alcohol‐Related and Nonalcoholic Fatty Liver Disease
por: Kjaergaard, Maria, et al.
Publicado: (2022)

A validated UHPLC-MS/MS method for rapid determination of senicapoc in plasma samples
por: Sørensen, Lambert K., et al.
Publicado: (2021)

Stronger findings from mass spectral data through multi-peak modeling
por: Suvitaival, Tommi, et al.
Publicado: (2014)

Stronger findings for metabolomics through Bayesian modeling of multiple peaks and compound correlations
por: Suvitaival, Tommi, et al.
Publicado: (2014)

Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial
por: Madsen, Bjørn Stæhr, et al.
Publicado: (2018)

High-Resolution Metabolomics of 50 Neurotransmitters and Tryptophan Metabolites in Feces, Serum, and Brain Tissues Using UHPLC-ESI-Q Exactive Mass Spectrometry
por: Lai, Yunjia, et al.
Publicado: (2021)

Lipidomic profiles, lipid trajectories and clinical biomarkers in female elite endurance athletes
por: Varga, Tibor V., et al.
Publicado: (2020)

Diclofenac Concentrations in Post-Mortem Specimens—Distribution, Case Reports, and Validated Method (UHPLC-QqQ-MS/MS) for Its Determination
por: Szpot, Paweł, et al.
Publicado: (2022)

A High-Throughput UHPLC-QqQ-MS Method for Polyphenol Profiling in Rosé Wines
por: Lambert, Marine, et al.
Publicado: (2015)

High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal
por: Kjærgaard, Maria, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b17s2j198icj4lu7d2kkjpheu4